An international collaboration results in the identification of a new cause of dwarfism: mutations in a gene known as DNMT3A.

A therapy derived from the eggs of parasitic worms helps to protect against one of chemotherapy’s debilitating side effects by significantly downregulating major proinflammatory pathways, reducing inflammation.

By monitoring the relative abundance of different bacteria types present in the urine of patients with spinal cord injury and combining this information with a patient’s symptoms doctors may be able to make more accurate diagnoses.

If the pilot findings are corroborated, the research represents the first step toward identifying a potential novel biomarker to guide interventions and better predict outcomes for children with autism.